4//SEC Filing
Morrow Phuong Khanh 4
Accession 0001209191-23-018561
CIK 0001674416other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:44 PM ET
Size
8.1 KB
Accession
0001209191-23-018561
Insider Transaction Report
Form 4
Morrow Phuong Khanh
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-10+44,620→ 44,620 totalExercise: $43.22Exp: 2033-03-10→ Common Shares (44,620 underlying) - Award
Restricted Stock Units
2023-03-10+22,000→ 22,000 total→ Common Shares (22,000 underlying)
Footnotes (3)
- [F1]This option was granted on March 10, 2023 with respect to 44,620 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001928989
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:44 PM ET
- Size
- 8.1 KB